An Entrepreneur’s Quest To Fix Drug Patents And Save Lives
Ford School hosts conversation on drug patent system reform
Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.
Senate Targets Hoarding of Drug Patents to Deter Competition
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
I-MAK Welcomes Two New Board Members to Champion the Access to Medicines Movement
California Says AbbVie Paid $1.2B In Kickbacks To Humira Ambassadors
‘Mentorship is a Conversation for Life’ Says the Mentor of This Social Entrepreneur
Would reforming the U.S. patent system help to lower drug prices?
China Patent Challenge Compels Gilead to Withdraw Key Patent Claims on Sofosbuvir Base Compound, Opening Life-Saving Hepatitis C Treatment Access for Millions
1
2